Alle pati - enterne havde fået Eprex/ Erypo, givet ved indsprøjtning i en vene, i mindst otte uger, før de enten skiftede til Abseamed eller fortsatte med Eprex/ Erypo.
All of the patients had been taking Eprex/ Erypo injected into a vein for at least eight weeks before they were either switched to Abseamed or remained on Eprex/ Erypo.